Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer-Reference-Cited by-同舟云学术

Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer

Published:2014-08 Issue:2 Volume:134 Page:346-355
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Schointuch Monica N.,Gilliam Timothy P.,Stine Jessica E.,Han Xiaoyun,Zhou Chunxiao,Gehrig Paola A.,Kim Kenneth,Bae-Jump Victoria L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. Cancer facts and figures;Society,2011

2. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis;Zhang;Int J Biol Markers,2014

3. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma;Matsuura;Oncol Rep,2011

4. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway;Gopalan;Cancer Lett,2013

5. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice;Cho;Int J Cancer,2008

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications;Cell Communication and Signaling;2024-09-10

2. Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy;Current Cancer Drug Targets;2024-09

3. Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study;BMC Cancer;2024-05-31

4. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study;Medicine;2024-05-03

5. How artificial intelligence can provide information about subdural hematoma: Assessment of readability, reliability, and quality of ChatGPT, BARD, and perplexity responses;Medicine;2024-05-03